Denmark, Norway halts AstraZeneca vaccination.


Denmark will not use AstraZeneca’s COVID-19 vaccine for two weeks after reports that some recipients had developed serious blood clots, and in one case may have died as a result, the country’s authorities said on Thursday.

They did not say how many reports of blood clots there had been, but Austria has stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.

“Both we and the Danish Medicines Agency have to respond to reports of possible serious side-effects, both from Denmark and other European countries,” the director of the Danish Health Authority, Soren Brostrom, said in a statement.

“It is currently not possible to conclude whether there is a link. We are acting early, it needs to be thoroughly investigated,” Health Minister Magnus Heunicke said on Twitter.

READ ALSO:EU calls for review after rising tensions with UK.

The vaccine would be suspended for 14 days, the health agency said. It did not give details of the Danish blood clot victim.

Norway follows suit

Following Denmark’s move, Norway announced later on Thursday that it was also halting the use of the AstraZeneca vaccine.

“This is a cautionary decision,” Geir Bukholm, director of infection prevention and control at the Norwegian Institute of Public Health, told a news conference.

AstraZeneca on Thursday told Reuters news agency in a written statement the safety of its vaccine had been extensively studied in human trials, and peer-reviewed data had confirmed the vaccine was generally well tolerated.

The drugmaker said earlier this week its shots were subject to strict and rigorous quality controls and that there had been “no confirmed serious adverse events associated with the vaccine”. It also said it was in contact with Austrian authorities and would fully support their investigation.

The European Union’s drug regulator, the European Medicines Agency (EMA), said on Wednesday there was no evidence so far linking AstraZeneca to the two cases in Austria.

It said the number of thromboembolic events – marked by the formation of blood clots – in people who have received the AstraZeneca vaccine is no higher than that seen in the general population, with 22 cases of such events being reported among the three million people who have received it as of March 9.

EMA was not immediately available for comment on Thursday.

Four other countries – Estonia, Lithuania, Luxembourg and Latvia – have stopped inoculations from the batch while an investigation continues, the EMA said.

The batch of one million doses went to 17 EU countries.

On hold, not opting out, says Denmark

The Danish Medicines Agency said it had launched an investigation into the vaccine together with corresponding agencies in other EU countries as well as the EMA.

“It is important to emphasise that we have not opted out of using the AstraZeneca vaccine, but that we are putting it on hold,” Brostrom said.

According to report from London, said the Danish move appeared to have “been borne of an abundance of caution”.

“The Danish Health Authority has not given any details of exactly how many blood clot cases there have been,” Brennan said.

“And they haven’t given any details of the background history of the one person who has died in Denmark. But what they did say it was that it was currently not possible to conclude there was a link between the vaccine and these deaths.”

So far, 136,090 Danes have received a shot with AstraZeneca’s vaccine in a country of 5.8 million. The Nordic country also uses vaccines from Pfizer-BioNTech and Moderna

Denmark’s Health Authority said it had pushed back the final date for when it expects all Danes to have been fully vaccinated by four weeks, to August 15, as a result of the suspension.

Sterghios Moschos, a molecular biologist at the UK’s Northumbria University, said Denmark, Norway and other governments were doing the correct thing to “stop and make sure everything was okay” before proceeding with further use.

“It’s an appropriate response, there is a concern that has been raised, and it needs to be looked at carefully and independently,” Moschos told reporters.

“But the likelihood, in general, that … a batch of the vaccine may have something wrong with it is very small.”

Spain on Thursday said it had not registered any cases of blood clots related to AstraZeneca’s vaccine so far and would continue administering the shots.

Watch Leakblast TV channel from around the world

Call Us:+234(0)9073726403
Get us on Whatsapp: +234(0)8181166425      
Email Us:


Good  journalism costs a lot of money.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble Endeavor.

By contributing to LeakBlast, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Support LeakBlast


Please enter your comment!
Please enter your name here